Longboard Pharmaceuticals (LBPH) Short Interest Ratio & Short Volume → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free LBPH Stock Alerts $21.14 +0.79 (+3.88%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Longboard Pharmaceuticals Short Interest DataCurrent Short Volume4,330,000 sharesPrevious Short Volume4,920,000 sharesChange Vs. Previous Month-11.99%Dollar Volume Sold Short$92.23 millionShort Interest Ratio / Days to Cover8.6Last Record DateApril 30, 2024Outstanding Shares38,880,000 sharesFloat Size33,260,000 sharesShort Percent of Float13.02%Today's Trading Volume188,049 sharesAverage Trading Volume1,122,930 sharesToday's Volume Vs. Average17% Short Selling Longboard Pharmaceuticals ? Sign up to receive the latest short interest report for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLBPH Short Interest Over TimeLBPH Days to Cover Over TimeLBPH Percentage of Float Shorted Over Time Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic Longboard Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,330,000 shares $92.23 million -12.0%13.0%8.6 $21.30 4/15/20244,920,000 shares $89.79 million -0.6%14.8%8.3 $18.25 3/31/20244,950,000 shares $106.92 million +32.4%14.9%7.7 $21.60 3/15/20243,740,000 shares $72.26 million +17.2%11.3%2.6 $19.32 2/29/20243,190,000 shares $70.75 million +0.3%9.9%2.3 $22.18 2/15/20243,180,000 shares $66.27 million +30.3%9.8%2.4 $20.84 Get the Latest News and Ratings for LBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,440,000 shares $51.83 million +43.5%7.9%2 $21.24 1/15/20241,700,000 shares $39.87 million +138.8%9.9%1.6 $23.45 12/31/2023711,800 shares $4.29 million +22.5%4.2%0.7 $6.03 12/15/2023581,200 shares $2.92 million +13.3%3.4%7.7 $5.02 11/30/2023512,800 shares $1.93 million +8.1%2.9%9.7 $3.76 11/15/2023474,400 shares $2.32 million -3.0%2.7%10.2 $4.88 10/31/2023488,800 shares $2.65 million -2.0%2.9%10.5 $5.42 10/15/2023498,500 shares $2.51 million -8.7%3.0%8.1 $5.03 9/30/2023546,200 shares $3.04 million -4.1%3.3%8.6 $5.56 9/15/2023569,600 shares $3.55 million -10.1%3.1%8.3 $6.23 8/31/2023633,900 shares $3.67 million -4.0%3.5%5.8 $5.79 8/15/2023660,300 shares $4.26 million +0.4%3.6%5.9 $6.45 7/31/2023657,800 shares $4.74 million -7.9%4.2%5.3 $7.20 7/15/2023714,400 shares $4.74 million -2.5%5.1%5.7 $6.64 6/30/2023732,800 shares $5.38 million +165.2%5.2%5.4 $7.34 6/15/2023276,300 shares $2.14 million +36.5%2.0%2.1 $7.76 5/31/2023202,400 shares $1.40 million +149.9%1.4%2.2 $6.93 5/15/202381,000 shares $718,470.00 +352.5%0.6%1 $8.87 4/30/202317,900 shares $148,212.00 +23.5%0.1%0.3 $8.28 4/15/202314,500 shares $88,160.00 +93.3%0.1%0.3 $6.08 3/31/20237,500 shares $30,075.00 -27.2%0.1%0.2 $4.01 3/15/202310,300 shares $49,337.00 -16.3%0.1%0.4 $4.79 2/28/202312,300 shares $62,238.00 -9.6%0.1%0.5 $5.06 2/15/202313,600 shares $67,864.00 -24.9%0.2%0.5 $4.99 1/31/202318,100 shares $77,106.00 +1.1%0.2%0.8 $4.26 1/15/202317,900 shares $105,699.50 +25.2%0.2%0.8 $5.91 12/30/202214,300 shares $46,618.00 -18.3%0.2%0.7 $3.26 12/15/202217,500 shares $70,350.00 -45.1%0.2%0.9 $4.02 11/30/202231,900 shares $171,303.00 -33.5%0.4%1.5 $5.37 11/15/202248,000 shares $227,520.00 +21.5%0.5%2.3 $4.74 10/31/202239,500 shares $146,150.00 -13.6%0.4%1.4 $3.70 10/15/202245,700 shares $150,810.00 -9.5%0.5%2.1 $3.30 9/30/202250,500 shares $187,860.00 +9.3%0.6%2.3 $3.72 9/15/202246,200 shares $198,660.00 +94.1%0.5%2.1 $4.30This unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company LBPH Short Interest - Frequently Asked Questions What is Longboard Pharmaceuticals' current short interest? Short interest is the volume of Longboard Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 4,330,000 shares of LBPH short. 13.02% of Longboard Pharmaceuticals' shares are currently sold short. Learn More on Longboard Pharmaceuticals' current short interest. What is a good short interest ratio for Longboard Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LBPH shares currently have a short interest ratio of 9.0. Learn More on Longboard Pharmaceuticals's short interest ratio. What is a good short interest percentage for Longboard Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.02% of Longboard Pharmaceuticals' floating shares are currently sold short. Is Longboard Pharmaceuticals' short interest increasing or decreasing? Longboard Pharmaceuticals saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 4,330,000 shares, a decline of 12.0% from the previous total of 4,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Longboard Pharmaceuticals' float size? Longboard Pharmaceuticals currently has issued a total of 38,880,000 shares. Some of Longboard Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Longboard Pharmaceuticals currently has a public float of 33,260,000 shares. How does Longboard Pharmaceuticals' short interest compare to its competitors? 13.02% of Longboard Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Longboard Pharmaceuticals: ALX Oncology Holdings Inc. (11.46%), Disc Medicine, Inc. (12.97%), Praxis Precision Medicines, Inc. (5.06%), Evolus, Inc. (9.69%), Arcturus Therapeutics Holdings Inc. (20.02%), Tango Therapeutics, Inc. (19.84%), Dianthus Therapeutics, Inc. (9.95%), Zentalis Pharmaceuticals, Inc. (24.64%), PureTech Health plc (0.02%), Aurinia Pharmaceuticals Inc. (8.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Longboard Pharmaceuticals stock? Short selling LBPH is an investing strategy that aims to generate trading profit from Longboard Pharmaceuticals as its price is falling. LBPH shares are trading up $0.79 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Longboard Pharmaceuticals? A short squeeze for Longboard Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LBPH, which in turn drives the price of the stock up even further. How often is Longboard Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LBPH, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ALXO Short Interest IRON Short Interest PRAX Short Interest EOLS Short Interest ARCT Short Interest TNGX Short Interest DNTH Short Interest ZNTL Short Interest PRTC Short Interest AUPH Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LBPH) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts